This project utilizes AQP4 antibody-based co-immunoprecipitation combined with mass spectrometry to compare changes in AQP4-binding proteins before and after intracerebral hemorrhage, aiming to identify and validate potential therapeutic targets and provide insights into the regulation of aquaporin-4 in post-hemorrhagic conditions.